
Your companion device for better health.
HQ: Paris, France
Product: Wearable microneedle patch for continuous potassium monitoring
Clinical focus: Detect and prevent dyskalemia for kidney and heart patients
Stage / funding: Pre-Seed; €2.3M total funding (last round 2024-03-26)
Headcount: ~17 employees
Chronic disease management for electrolyte imbalances (dyskalemia) in kidney and heart disease patients.
2021
Medtech / Wearable biosensors
Investors listed include Bpifrance and Advans.